Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy.
International Journal Of Molecular Sciences
Delgado-Minjares, Karen M KM; Martinez-Fong, Daniel D; Martínez-Dávila, Irma A IA; Bañuelos, Cecilia C; Gutierrez-Castillo, M E ME; Blanco-Alvarez, Víctor Manuel VM; Cardenas-Aguayo, Maria-Del-Carmen MD; Luna-Muñoz, José J; Pacheco-Herrero, Mar M; Soto-Rojas, Luis O LO
Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.
Cell Death & Disease
Gibbs, Katherine L KL; Kalmar, Bernadett B; Rhymes, Elena R ER; Fellows, Alexander D AD; Ahmed, Mahmood M; Whiting, Paul P; Davies, Ceri H CH; Greensmith, Linda L; Schiavo, Giampietro G
Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.